Directory
>
Erik Bush
Erik Bush
Senior Vice President, Biology | Arrowhead Pharmaceuticals
Madison, Wisconsin, United States
Erik Bush
Summary
Erik Bush is a seasoned leader in the biopharmaceutical industry, currently serving as the Senior Vice President of Biology at Arrowhead Pharmaceuticals. With over 20 years of experience, he specializes in drug discovery and preclinical research, particularly in epigenetic therapies targeting cardiovascular and pulmonary diseases. Erik has a strong track record in project and portfolio management, having successfully led cross-functional teams in various capacities throughout his career. His expertise spans assay development, molecular pharmacology, and translational research, complemented by a solid foundation in technical writing and regulatory processes. Erik's commitment to innovation is evident in his numerous publications and patents, showcasing his contributions to advancing therapeutic solutions. He holds a Ph.D. in Cellular and Developmental Biology and a B.A./B.S. in Biology and Chemistry, underscoring his strong educational background in the life sciences.
Erik Bush
Work Experience
Senior Vice President, Biology at
Arrowhead Pharmaceuticals
October 2023 - Present
Group Vice President, Biology at
Arrowhead Pharmaceuticals
November 2020 - October 2023
Vice President, Biology at
Arrowhead Pharmaceuticals
May 2019 - November 2020
Sr. Director, Biology at
Arrowhead Pharmaceuticals
January 2018 - May 2019
Director, Extrahepatic Targeting at
Arrowhead Pharmaceuticals
November 2015 - December 2017
Group Leader, Biology at
Arrowhead Pharmaceuticals
December 2014 - November 2015
Senior Director, Research at
Viridian Therapeutics, Inc.
January 2014 - December 2014
Director, Translational Research and Program Management at
Miragen Therapeutics
February 2013 - January 2014
Senior Project Manager at
Miragen Therapeutics
January 2012 - January 2013
Manager, Project Management, Genomic Technologies at
Thermo Fisher Scientific
June 2011 - January 2012
Senior Project Manager, Genomic Technologies at
Thermo Fisher Scientific
February 2010 - June 2011
Senior Research Scientist II at
Gilead Sciences
January 2008 - December 2009
Senior Research Scientist I at
Gilead Colorado
January 2007 - January 2008
Scientist III at
Myogen - Performance | Movement | Therapy
January 2006 - January 2007
Scientist II at
Myogen - Performance | Movement | Therapy
January 2004 - January 2006
Scientist I at
Myogen - Performance | Movement | Therapy
February 2001 - January 2004
Postdoctoral Fellow at
Myogen - Performance | Movement | Therapy
December 1999 - February 2001
Research Associate at
University of Colorado Health Sciences Center
August 1991 - July 1995
Erik Bush
Education
University of Colorado Anschutz Medical Campus, Ph.D.
January 1995 - January 1999
University of Wisconsin–Eau Claire, B.A. / B.S.
January 1985 - January 1989
Frequently Asked Questions about Erik Bush
What is Erik Bush email address?
Erik Bush's primary email address is *********@arrowheadpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Erik Bush work for?
Erik Bush is a Senior Vice President, Biology at Arrowhead Pharmaceuticals, a company specializing in Biological products, except diagnostic.
Where Erik Bush graduated from?
Erik Bush holds a degree in Cellular And Developmental Biology from University of Colorado Anschutz Medical Campus.
How can I directly contact Erik Bush?
To contact Erik Bush directly, you can use the email address *********@arrowheadpharma.com. Complete contact information is available upon registration with Muraena.
Who is Erik Bush?
Erik Bush is a seasoned leader in the biopharmaceutical industry, currently serving as the Senior Vice President of Biology at Arrowhead Pharmaceuticals. With over 20 years of experience, he specializes in drug discovery and preclinical research, particularly in epigenetic therapies targeting cardiovascular and pulmonary diseases. Erik has a strong track record in project and portfolio management, having successfully led cross-functional teams in various capacities throughout his career. His expertise spans assay development, molecular pharmacology, and translational research, complemented by a solid foundation in technical writing and regulatory processes. Erik's commitment to innovation is evident in his numerous publications and patents, showcasing his contributions to advancing therapeutic solutions. He holds a Ph.D. in Cellular and Developmental Biology and a B.A./B.S. in Biology and Chemistry, underscoring his strong educational background in the life sciences.
Erik`s contact details
*********@arrowheadpharma.com
Colleagues
Member, Board of Directors
Vice President, Clinical Operations
Senior Vice President, CMC and Developmental Chemistry
Executive Director Program Management
Senior Vice President, Chemistry
Group Vice President, Program Management
Managing Director
Executive Director
Vice President, Cardiovascular/Metabolic Franchise Head
Vice President, Head of Business Development and New Product Planning